A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)
Clinical trial NCT01460719 · COMPLETED
Trial details
- NCT number
- NCT01460719
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-24
- Primary completion
- 2012-09-25
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.